Overview
The study aims to optimize individualized treatment of anti-infective drugs in osteoarticular infections by analyzing drug exposure in patients blood and/or tissues using population pharmacokinetics.
Eligibility
Inclusion Criteria:
- Patients with suspected/confirmed osteoarticular infections who are undergoing anti-infective drug therapy.
Exclusion Criteria:
- Pregnant/lactating women.
- There are other factors that the researchers think are not suitable for inclusion.